HomeAuthorsPosts by admin

admin

1868 POSTS6 COMMENTS

Latest Pharma-News

FDA Takes Additional Steps to Advance Decentralized Clinical Trials

admin - May 4, 2023 0

Latest Pharma-News

FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

admin - May 4, 2023 0

Latest Pharma-News

Bayer and Cat Creek Energy Sign Landmark Renewable Energy Deal

admin - May 4, 2023 0

Latest Pharma-News

Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines

admin - May 4, 2023 0

Latest Pharma-News

XTANDI® plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide

admin - April 30, 2023 0

Latest Pharma-News

Update on FDA Advisory Committee vote on Lynparza plus abiraterone for metastatic castration-resistant prostate cancer

admin - April 30, 2023 0

Latest Pharma-News

EMA validates marketing authorisation application for Jemperli plus chemotherapy for dMMR/MSI-H primary advanced or recurrent endometrial cancer

admin - April 25, 2023 0

Latest Pharma-News

FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines

admin - April 21, 2023 0

Latest Pharma-News

Bayer’s New data from pivotal studies with aflibercept 8 mg

admin - April 21, 2023 0

Uncategorized

BMS Submits Application for Abecma® for Relapsed or Refractory Multiple Myeloma

admin - April 19, 2023 0

Latest Pharma-News

FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

admin - April 19, 2023 0

Latest Pharma-News

Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi

admin - April 11, 2023 0

1 234...156 Page 3 of 156

TOP AUTHORS

admin

1868 POSTS6 COMMENTS

OIdMIHuOdiu

0 POSTS0 COMMENTS

tintin

0 POSTS0 COMMENTS

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

February 10, 2025

Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium

February 3, 2025

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

February 3, 2025

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

January 24, 2025

admin

TOP AUTHORS

Most Read

FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices

Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium

FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

CRASH COURSE ON CLINICAL DATA MANAGEMENT

Interview Questions on Institutional Review Board(IRB)

POPULAR POSTS

How to Find Paid Clinical Trials Near You

What Is CDISC and What Are CDISC Data Standards?

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

POPULAR CATEGORY

ABOUT US

FOLLOW US